“Evidence-Based Prioritization and Scoring of Genomic Loci Interacting with Pioglitazone Therapeutic Response in Diabetic Patients”. (2022) Precision Medicine Communications, 2(2), pp. 91–108. doi:10.55627/pmc.002.02.0188.